Cargando…
Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
Super-statins are synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which is the rate-limiting enzyme responsible for the biosynthesis of cholesterol. All of the super-statins with a C=C double bond spacer between the heterocyclic and the dihydroxycarboxylic moiety that are cu...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270003/ https://www.ncbi.nlm.nih.gov/pubmed/24169468 http://dx.doi.org/10.3390/molecules181113283 |
_version_ | 1783376598241640448 |
---|---|
author | Makuc, Damjan Fabris, Jan Časar, Zdenko Plavec, Janez |
author_facet | Makuc, Damjan Fabris, Jan Časar, Zdenko Plavec, Janez |
author_sort | Makuc, Damjan |
collection | PubMed |
description | Super-statins are synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which is the rate-limiting enzyme responsible for the biosynthesis of cholesterol. All of the super-statins with a C=C double bond spacer between the heterocyclic and the dihydroxycarboxylic moiety that are currently on the market exist as E-isomers. To extend the understanding of conformational and thermodynamic preferences of Z-isomeric super-statin analogues, this study focused on analyzing pitavastatin and its lactonized derivatives via NMR spectroscopy and ab initio calculations. Z-isomeric pitavastatin analogues exist in solution as a pair of interconverting rotamers, where the Gibbs free energies between the major and minor rotamers are within 0.12 and 0.25 kcal mol(−1) and the rotational energy barriers are between 15.0 and 15.9 kcal mol(−1). The analysis of long-range coupling constants and ab initio calculations revealed that rotation across the C5'–C7 single bond is essential for generating a pair of atropisomers. The overall comparison of the results between Z-isomeric pitavastatin and rosuvastatin analogues demonstrated that the former are to some extent more flexible to attain numerous conformations. Demonstrating how structural differences between super-statin analogues induce distinctive conformational preferences provides important insight into the super-statins’ conformational variability and may well improve future drug design. |
format | Online Article Text |
id | pubmed-6270003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62700032018-12-20 Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues Makuc, Damjan Fabris, Jan Časar, Zdenko Plavec, Janez Molecules Article Super-statins are synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, which is the rate-limiting enzyme responsible for the biosynthesis of cholesterol. All of the super-statins with a C=C double bond spacer between the heterocyclic and the dihydroxycarboxylic moiety that are currently on the market exist as E-isomers. To extend the understanding of conformational and thermodynamic preferences of Z-isomeric super-statin analogues, this study focused on analyzing pitavastatin and its lactonized derivatives via NMR spectroscopy and ab initio calculations. Z-isomeric pitavastatin analogues exist in solution as a pair of interconverting rotamers, where the Gibbs free energies between the major and minor rotamers are within 0.12 and 0.25 kcal mol(−1) and the rotational energy barriers are between 15.0 and 15.9 kcal mol(−1). The analysis of long-range coupling constants and ab initio calculations revealed that rotation across the C5'–C7 single bond is essential for generating a pair of atropisomers. The overall comparison of the results between Z-isomeric pitavastatin and rosuvastatin analogues demonstrated that the former are to some extent more flexible to attain numerous conformations. Demonstrating how structural differences between super-statin analogues induce distinctive conformational preferences provides important insight into the super-statins’ conformational variability and may well improve future drug design. MDPI 2013-10-28 /pmc/articles/PMC6270003/ /pubmed/24169468 http://dx.doi.org/10.3390/molecules181113283 Text en © 2013 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0/ This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Article Makuc, Damjan Fabris, Jan Časar, Zdenko Plavec, Janez Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title | Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title_full | Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title_fullStr | Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title_full_unstemmed | Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title_short | Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues |
title_sort | conformational analysis of geometric isomers of pitavastatin together with their lactonized analogues |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6270003/ https://www.ncbi.nlm.nih.gov/pubmed/24169468 http://dx.doi.org/10.3390/molecules181113283 |
work_keys_str_mv | AT makucdamjan conformationalanalysisofgeometricisomersofpitavastatintogetherwiththeirlactonizedanalogues AT fabrisjan conformationalanalysisofgeometricisomersofpitavastatintogetherwiththeirlactonizedanalogues AT casarzdenko conformationalanalysisofgeometricisomersofpitavastatintogetherwiththeirlactonizedanalogues AT plavecjanez conformationalanalysisofgeometricisomersofpitavastatintogetherwiththeirlactonizedanalogues |